Business, energy, technology, markets and global industry news from Business News Today

Rachel McMinn

PharmaDeviceNews Rachel McMinn
A representative image illustrating Teva Pharmaceutical Industries’ ecopipam program as the FDA grants Priority Review for the investigational pediatric Tourette syndrome treatment following positive Phase 3 relapse-prevention data.
Pharma & Biotech

Neurogene reports rapid MECP2 expression and new gene regulation data for NGN-401 in Rett syndrome

Neurogene reports rapid MECP2 expression and new regulation data for NGN-401, strengthening its Rett syndrome research ahead of 2027 results.

Read More